16th Jun 2026 15:32
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Forgent PLC - London-based provider of syngas technology and engineering services for converting waste into sustainable energy and biofuels, and also has copper and gold assets - Pretax loss narrows to EUR14.2 million in 2025 from EUR19.4 million the year prior, while revenue more than halves to EUR1.0 million from EUR2.2 million. Bottom line benefits from lower finance costs and administrative expenses. In addition, impairment of equity-accounted investments drops to EUR2.0 million from EUR5.4 million, and impairment of trade and receivable falls to EUR70,500 from EUR6.3 million. This offsets quadruling in impairment of goodwill to EUR8.0 million from EUR2.0 million. "During the year, we recognised impairment charges on certain assets to reflect current market conditions, updated business forecasts, and the recoverable value of those assets. We undertook a comprehensive review of our asset portfolio in the gasification business and recognised impairments where carrying values no longer reflected expected future economic benefits. This led to a full impairment of all gasification related assets with the exception of Technology Patent Assets. This action strengthens the quality of our balance sheet and supports disciplined capital allocation going forward," the company says. Chief Executive James Parsons says Forgent now operates with a "leaner cost structure, enhanced portfolio of assets, and clear focus on execution, creating strong operational momentum across the business," leaving it "well-positioned to rebuild value and deliver impactful results."
----------
IG Design Group PLC - Buckinghamshire, England-based celebration products and gift packaging firm - Pretax profit drops to GBP6.3 million in the financial year ended March 31 from GBP9.0 million the year prior, or to GBP8.6 million from GBP14.9 million on an adjusted basis. Revenue edges down to GBP217.9 million from GBP225.4 million, although diluted earnings per share total 5.5 pence, up from 4.3p. The fall in sales reflects the impact of tariffs, pricing pressures and softer UK demand, IG Design says. Restores dividend with a 1.0p per share payout after passing a year ago. This forms part of a new capital allocation framework prioritising growth, a progressive dividend policy and the return of surplus capital. IG plans to buyback up to 10% of its share capital, starting Tuesday and ending by September 24. This will be run by Canaccord Genuity Ltd. Looking ahead, IG Design acknowledges the "ongoing macroeconomic uncertainty, including cost pressures, inflation, and softer consumer sentiment", but "remains confident" of delivery in the period ahead. Guidance remains unchanged and it expects to deliver 0% to 5% revenue growth, adjusted operating margins of 4% to 5% and around GBP5 million annual free cash generation in the current financial year.
----------
Christie Group PLC - London-based provider of professional services, including stock and inventory systems, for customers in the hospitality, leisure, healthcare, medical, childcare, education and retail sectors - Says it continues to see robust levels of demand for its services in the five months ended May 31, with lender and investor appetite for its chosen sectors remaining resilient. Based on anticipated pipeline conversion and deal flow throughout the remainder of 2026, Christie once again anticipates selling in excess of 1,000 businesses in the year. With a strong pipeline of deals due to complete over the coming months, the group anticipates a second-half weighting to its full year revenue and profits. "While the group remains mindful of ongoing geopolitical uncertainty which is contributing to slightly elongated deal timelines, our activity levels, coupled with continued investor and lender appetite for our sectors underpin the board's continued confidence in the group's long-term growth opportunities and delivering a full year performance in line with board expectations," it says.
----------
Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm focused on cancer immunotherapy - Receives formal notification of the decision to grant for its POLB 001 cancer immunotherapy-induced cytokine release syndrome patent application from the European Patent Office. This represents a "significant milestone" for the company's global intellectual property strategy, Poolbeg says. The European patent, which provides protection across EPO member states, is the most "commercially significant grant to date" within Poolbeg's cancer immunotherapy-induced CRS patent family, covering one of the world's largest and most important pharmaceutical markets, it adds. This follows the grant of the first patent by IP Australia in March, a patent grant in Canada in May, and further reinforces the company's commitment to building a "robust, worldwide IP portfolio". With the TOPICAL trial on track to deliver interim data later this summer, Poolbeg believes this milestone significantly enhances POLB 001's "attractiveness to potential partners and its long-term value proposition".
----------
Cizzle Biotechnology Holdings PLC - London-based life sciences company - Announces the successful laboratory accreditation of its proprietary test for the CIZ1B biomarker, which is highly associated with early-stage lung cancer. The test is now approved for use under Clinical Laboratory Improvement Amendments accreditation at OmniHealth Diagnostics, a CLIA-certified, COLA-accredited clinical laboratory based in Dallas, Texas. This means the CIZ1B biomarker test is accredited for clinical use in the US under CLIA, providing a regulated US laboratory route to market for the early lung cancer blood test. CLIA accreditation meets US federal standards for "timely, accurate and reliable clinical testing and patient safety" and enables licensed US healthcare providers to order the test signifying commercial launch. This in turn establishes the foundation for "revenue generation, reimbursement pathways and wider US adoption."
----------
Pri0r1ty Intelligence Group PLC - London-based software-as-a-service company focused on AI - Announces that its Halfspace Ltd business has entered into a partnership agreement with the Sport & Recreation Alliance as its official AI partner. Halfspace will offer data solutions and AI tools to nearly 300 member organisations across the sports and recreation sector with an estimated 15,000 users through SportTower.ai, the company's new platform for the sports and recreation sector. The 12-month agreement, with an option to extend, marks the first deployment of SportTower.ai and the launch of the company's strategy to bring its AI platform to multiple sectors through strategic partnerships. Intends to replicate this model through further partnerships over the coming months. Halfspace has worked with The Alliance to agree this partnership and expects to derive revenues as Alliance members sign up for Halfspace products.
----------
By Jeremy Cutler, Alliance News reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
ForgentDesign GroupChristiePoolbeg PharmaCizzle BiotechPri0r1ty Int